OTCMKTS:SUWN

Sunwin Stevia International Competitors

$0.05

0.00 (0.00 %)

(As of 05/17/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.05

▼

$0.05

50-Day Range

$0.05

▼

$0.07

52-Week Range

$0.04

▼

$0.15

Volume10,500 shs

Average Volume65,617 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

Beta1.18

Sunwin Stevia International (OTCMKTS:SUWN) Vs. ACUS, AFFY, ARYX, AHROQ, CBPI, and CDSG

Should you be buying SUWN stock or one of its competitors? Companies in the industry of "pharmaceutical preparations" are considered alternatives and competitors to Sunwin Stevia International, including Acusphere (ACUS), Affymax (AFFY), ARYx Therapeutics (ARYX), AtheroNova (AHROQ), China Botanic Pharmaceutical (CBPI), and China Dongsheng International (CDSG).

Sunwin Stevia International vs. Acusphere Stock

Sunwin Stevia International (OTCMKTS:SUWN) and Acusphere (OTCMKTS:ACUS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation.

Valuation and Earnings

This table compares Sunwin Stevia International and Acusphere's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sunwin Stevia International	$26.09 million	N/A	$-1,380,000.00	N/A	N/A
Acusphere	N/A	N/A	N/A	N/A	N/A

Acusphere has lower revenue, but higher earnings than Sunwin Stevia International.

Risk and Volatility

Sunwin Stevia International has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Acusphere has a beta of -0.25, indicating that its stock price is 125% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and target prices for Sunwin Stevia International and Acusphere, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sunwin Stevia International	0	0	0	0	N/A
Acusphere	0	0	0	0	N/A

Profitability

This table compares Sunwin Stevia International and Acusphere's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sunwin Stevia International	-9.56%	-24.05%	-7.89%
Acusphere	N/A	N/A	N/A

Summary

Acusphere beats Sunwin Stevia International on 3 of the 5 factors compared between the two stocks.

Sunwin Stevia International vs. Affymax Stock

Sunwin Stevia International (OTCMKTS:SUWN) and Affymax (OTCMKTS:AFFY) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation.

Valuation and Earnings

This table compares Sunwin Stevia International and Affymax's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sunwin Stevia International	$26.09 million	N/A	$-1,380,000.00	N/A	N/A
Affymax	N/A	N/A	N/A	N/A	N/A

Affymax has lower revenue, but higher earnings than Sunwin Stevia International.

Risk and Volatility

Sunwin Stevia International has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Affymax has a beta of 2.77, indicating that its stock price is 177% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and target prices for Sunwin Stevia International and Affymax, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sunwin Stevia International	0	0	0	0	N/A
Affymax	0	0	0	0	N/A

Profitability

This table compares Sunwin Stevia International and Affymax's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sunwin Stevia International	-9.56%	-24.05%	-7.89%
Affymax	N/A	N/A	N/A

Summary

Affymax beats Sunwin Stevia International on 4 of the 5 factors compared between the two stocks.

Sunwin Stevia International vs. ARYx Therapeutics Stock

Sunwin Stevia International (OTCMKTS:SUWN) and ARYx Therapeutics (OTCMKTS:ARYX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation.

Valuation and Earnings

This table compares Sunwin Stevia International and ARYx Therapeutics' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sunwin Stevia International	$26.09 million	N/A	$-1,380,000.00	N/A	N/A
ARYx Therapeutics	N/A	N/A	N/A	N/A	N/A

ARYx Therapeutics has lower revenue, but higher earnings than Sunwin Stevia International.

Risk and Volatility

Sunwin Stevia International has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, ARYx Therapeutics has a beta of -0.53, indicating that its stock price is 153% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and target prices for Sunwin Stevia International and ARYx Therapeutics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sunwin Stevia International	0	0	0	0	N/A
ARYx Therapeutics	0	0	0	0	N/A

Profitability

This table compares Sunwin Stevia International and ARYx Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sunwin Stevia International	-9.56%	-24.05%	-7.89%
ARYx Therapeutics	N/A	N/A	N/A

Summary

ARYx Therapeutics beats Sunwin Stevia International on 3 of the 5 factors compared between the two stocks.

Sunwin Stevia International vs. AtheroNova Stock

Sunwin Stevia International (OTCMKTS:SUWN) and AtheroNova (OTCMKTS:AHROQ) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation.

Profitability

This table compares Sunwin Stevia International and AtheroNova's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sunwin Stevia International	-9.56%	-24.05%	-7.89%
AtheroNova	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and target prices for Sunwin Stevia International and AtheroNova, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sunwin Stevia International	0	0	0	0	N/A
AtheroNova	0	0	0	0	N/A

Valuation and Earnings

This table compares Sunwin Stevia International and AtheroNova's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sunwin Stevia International	$26.09 million	N/A	$-1,380,000.00	N/A	N/A
AtheroNova	N/A	N/A	N/A	N/A	N/A

AtheroNova has lower revenue, but higher earnings than Sunwin Stevia International.

Risk and Volatility

Sunwin Stevia International has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, AtheroNova has a beta of -8.71, indicating that its stock price is 971% less volatile than the S&P 500.

Summary

AtheroNova beats Sunwin Stevia International on 3 of the 5 factors compared between the two stocks.

Sunwin Stevia International vs. China Botanic Pharmaceutical Stock

China Botanic Pharmaceutical (OTCMKTS:CBPI) and Sunwin Stevia International (OTCMKTS:SUWN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk.

Profitability

This table compares China Botanic Pharmaceutical and Sunwin Stevia International's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
China Botanic Pharmaceutical	N/A	N/A	N/A
Sunwin Stevia International	-9.56%	-24.05%	-7.89%

Analyst Ratings

This is a breakdown of recent ratings and price targets for China Botanic Pharmaceutical and Sunwin Stevia International, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
China Botanic Pharmaceutical	0	0	0	0	N/A
Sunwin Stevia International	0	0	0	0	N/A

Valuation & Earnings

This table compares China Botanic Pharmaceutical and Sunwin Stevia International's revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
China Botanic Pharmaceutical	N/A	N/A	N/A	N/A	N/A
Sunwin Stevia International	$26.09 million	N/A	$-1,380,000.00	N/A	N/A

China Botanic Pharmaceutical has higher earnings, but lower revenue than Sunwin Stevia International.

Risk & Volatility

China Botanic Pharmaceutical has a beta of 17.09, indicating that its stock price is 1,609% more volatile than the S&P 500. Comparatively, Sunwin Stevia International has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500.

Summary

China Botanic Pharmaceutical beats Sunwin Stevia International on 4 of the 5 factors compared between the two stocks.

Sunwin Stevia International vs. China Dongsheng International Stock

China Dongsheng International (OTCMKTS:CDSG) and Sunwin Stevia International (OTCMKTS:SUWN) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk.

Profitability

This table compares China Dongsheng International and Sunwin Stevia International's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
China Dongsheng International	N/A	N/A	N/A
Sunwin Stevia International	-9.56%	-24.05%	-7.89%

Analyst Ratings

This is a breakdown of recent ratings and price targets for China Dongsheng International and Sunwin Stevia International, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
China Dongsheng International	0	0	0	0	N/A
Sunwin Stevia International	0	0	0	0	N/A

Valuation & Earnings

This table compares China Dongsheng International and Sunwin Stevia International's revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
China Dongsheng International	N/A	N/A	N/A	N/A	N/A
Sunwin Stevia International	$26.09 million	N/A	$-1,380,000.00	N/A	N/A

China Dongsheng International has higher earnings, but lower revenue than Sunwin Stevia International.

Risk & Volatility

China Dongsheng International has a beta of 13.38, indicating that its stock price is 1,238% more volatile than the S&P 500. Comparatively, Sunwin Stevia International has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500.

Summary

China Dongsheng International beats Sunwin Stevia International on 4 of the 5 factors compared between the two stocks.